Journal rankings · indicator year 2017
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2017
Hematology journal rankings 2017
74 ranked journals · Subfield in Medicine
Hematology has 74 ranked journals in 2017. The median journal has an OJR of 0.75, below the world average of 1.00, up 0.03 on 2016; Q1 starts at OJR 1.22. The top three are Blood, Blood Reviews, and Leukemia.
Ranks and citation indicators: 2017. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2014–2016, the window the 2017 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery852
- Pulmonary and Respiratory Medicine324
- Public Health, Environmental and Occupational Health270
- Cardiology and Cardiovascular Medicine266
- Oncology213
- Infectious Diseases198
- Epidemiology185
- Neurology157
- Endocrinology, Diabetes and Metabolism156
- Radiology, Nuclear Medicine and Imaging144
- Physiology143
- Psychiatry and Mental health142
- Hematology74
Show all 42 subfields
- Orthopedics and Sports Medicine107
- Pediatrics, Perinatology and Child Health97
- Ophthalmology87
- Dermatology83
- Obstetrics and Gynecology68
- Rheumatology65
- Nephrology58
- Reproductive Medicine50
- Complementary and alternative medicine47
- Pharmacology46
- Emergency Medicine38
- Geriatrics and Gerontology35
- Otorhinolaryngology32
- Rehabilitation29
- Pathology and Forensic Medicine25
- Critical Care and Intensive Care Medicine23
- Hepatology23
- Genetics21
- Immunology and Allergy20
- Urology13
- Anesthesiology and Pain Medicine12
- Gastroenterology7
- Internal Medicine4
- Family Practice3
- Transplantation3
- Health Informatics2
- Anatomy0
- Biochemistry0
- Microbiology0
74 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2016. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2014–2016, the window the 2017 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2014–2016 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2008 to 2017. | Compare |
|---|---|---|---|---|---|---|---|
1BloodElsevier BV · United States | 3.43Q1 | 9.66 0.96 up from 2016 | 3,307 | 15% | $5,500 | ||
2Blood ReviewsElsevier BV · United Kingdom | 3.05Q1 | 6.84 0.33 up from 2016 | 146 | 34% | $5,220 | ||
3LeukemiaSpringer Nature · United Kingdom | 2.58Q1 | 6.42 0.68 down from 2016 | 1,070 | 67% | $5,190 | ||
4The Lancet HaematologyElsevier BV · Netherlands | 2.56Q1 | 6.33 1.31 up from 2016 | 229 | 39% | $7,280 | ||
5Seminars in HematologyElsevier BV · United States | 2.05Q1 | 5.26 0.13 up from 2016 | 128 | 22% | $4,070 | ||
6Therapeutic Advances in HematologyOASAGE Publishing · United Kingdom | 1.94Q1 | 5.18 1.07 up from 2016 | 81 | 100% | $2,650 | ||
7HaematologicaOAFerrata Storti Foundation · Italy | 1.92Q1 | 4.84 0.19 up from 2016 | 1,039 | 100% | $2,157 | ||
8Journal of Thrombosis and HaemostasisElsevier BV · United Kingdom | 1.84Q1 | 4.54 0.25 down from 2016 | 936 | 96% | $3,750 | ||
9Transfusion Medicine ReviewsElsevier BV · United States | 1.83Q1 | 4.45 3.28 down from 2016 | 94 | 10% | $3,970 | ||
10Blood Cancer JournalOASpringer Nature · United Kingdom | 1.74Q1 | 4.59 0.18 down from 2016 | 329 | 100% | $5,290 | ||
11Transplantation and Cellular TherapyElsevier BV · Netherlands | 1.72Q1 | 4.48 0.16 down from 2016 | 1,013 | 100% | $3,650 | ||
12British Journal of HaematologyWiley · United Kingdom | 1.65Q1 | 3.91 0.37 down from 2016 | 1,483 | 58% | $5,190 | ||
13American Journal of HematologyWiley · United States | 1.65Q1 | 4.28 0.13 down from 2016 | 861 | 87% | $5,450 | ||
14Journal of Blood MedicineOADove Medical Press · New Zealand | 1.49Q1 | 3.49 0.13 up from 2016 | 86 | 100% | $2,320 | ||
15Seminars in Thrombosis and HemostasisThieme Medical Publishers (Germany) · United States | 1.43Q1 | 3.92 0.40 up from 2016 | 354 | 36% | — | ||
16AnemiaOAHindawi Publishing Corporation · United Kingdom | 1.42Q1 | 2.43 0.81 down from 2016 | 40 | 100% | $1,100 | ||
17HematologyAmerican Society of Hematology · United States | 1.39Q1 | 3.20 0.37 up from 2016 | 300 | 100% | — | ||
18Current Opinion in HematologyLippincott Williams & Wilkins · United States | 1.35Q1 | 3.36 0.20 down from 2016 | 231 | 41% | — | ||
19Bone Marrow TransplantationSpringer Nature · United Kingdom | 1.22Q1 | 3.12 0.17 up from 2016 | 973 | 31% | $4,990 | ||
20Transfusion Medicine and HemotherapyOAKarger Publishers · Switzerland | 1.16Q2 | 2.59 0.46 up from 2016 | 162 | 78% | $1,670 | ||
21TransfusionWiley · United States | 1.09Q2 | 3.10 0.25 down from 2016 | 1,271 | 39% | $4,100 | ||
22Blood AdvancesOAElsevier BV · United States | 1.07Q2 | 2.59no 2016 value | 32 | 100% | $3,800 | — | |
23Pediatric RheumatologyOABioMed Central · United Kingdom | 1.06Q2 | 2.70 0.58 up from 2016 | 232 | 100% | $3,090 | ||
24Current Hematologic Malignancy ReportsSpringer Science+Business Media · United States | 1.06Q2 | 3.07 0.67 up from 2016 | 166 | 24% | $3,790 | ||
25Vox SanguinisWiley · United Kingdom | 0.99Q2 | 2.55 0.22 up from 2016 | 290 | 29% | $4,150 | ||
26European Journal Of HaematologyWiley · United Kingdom | 0.95Q2 | 2.47 0.04 up from 2016 | 512 | 22% | $4,650 | ||
27Experimental HematologyElsevier BV · United States | 0.94Q2 | 2.71 0.19 down from 2016 | 365 | 100% | $3,250 | ||
28PlateletsOAInforma · United Kingdom | 0.90Q2 | 2.58 0.38 up from 2016 | 336 | 44% | $2,970 | ||
29Leukemia ResearchElsevier BV · United Kingdom | 0.89Q2 | 2.34 0.19 down from 2016 | 609 | 11% | $3,910 | ||
30Best Practice & Research Clinical HaematologyElsevier BV · United Kingdom | 0.89Q2 | 1.95 0.91 down from 2016 | 125 | 6% | $3,730 | ||
31Clinical Lymphoma Myeloma & LeukemiaElsevier BV · United States | 0.88Q2 | 2.34 0.24 up from 2016 | 440 | 5% | $3,890 | ||
32Current Research in Translational MedicineElsevier BV · France | 0.87Q2 | 1.74 0.24 up from 2016 | 46 | 13% | $3,700 | ||
33BMC HematologySpringer Science+Business Media · United Kingdom | 0.85Q2 | 1.91 0.57 up from 2016 | 64 | 100% | $2,170 | ||
34Annals of HematologyOASpringer Science+Business Media · Germany | 0.84Q2 | 2.14 0.39 down from 2016 | 889 | 21% | $4,590 | ||
35Expert Review of HematologyTaylor & Francis · United Kingdom | 0.84Q2 | 2.07 0.09 down from 2016 | 282 | 28% | — | ||
36International Journal of HematologySpringer Science+Business Media · Japan | 0.79Q2 | 2.31 0.47 up from 2016 | 625 | 20% | $4,390 | ||
37Mediterranean Journal of Hematology and Infectious DiseasesOAPAGEPress (Italy) · Italy | 0.76Q2 | 1.64 0.28 down from 2016 | 199 | 100% | $647 | ||
38Journal of Clinical ApheresisWiley · United States | 0.75Q3 | 2.33 0.53 up from 2016 | 184 | 13% | $3,920 | ||
39International Journal of Laboratory HematologyWiley · United Kingdom | 0.69Q3 | 1.80 0.20 up from 2016 | 391 | 23% | $3,880 | ||
40HaemophiliaWiley · United Kingdom | 0.68Q3 | 1.94 0.44 down from 2016 | 722 | 29% | $4,760 | ||
41Leukemia & lymphoma/Leukemia and lymphomaTaylor & Francis · Switzerland | 0.67Q3 | 1.66 0.15 down from 2016 | 1,437 | 26% | — | ||
42Cytometry Part B Clinical CytometryWiley · United States | 0.65Q3 | 2.17 0.25 up from 2016 | 267 | 76% | $3,800 | ||
43Transfusion MedicineWiley · United Kingdom | 0.64Q3 | 1.75 0.23 up from 2016 | 231 | 19% | $3,700 | ||
44Annals of Laboratory MedicineOASeoul National University · South Korea | 0.63Q3 | 1.46 0.28 down from 2016 | 375 | 100% | — | ||
45Transfusion and Apheresis ScienceElsevier BV · United Kingdom | 0.60Q3 | 1.91 0.35 up from 2016 | 415 | 7% | $3,160 | ||
46Pediatric Hematology and OncologyTaylor & Francis · United Kingdom | 0.59Q3 | 1.24 0.13 down from 2016 | 185 | 21% | — | ||
47Asian Journal of Transfusion ScienceOAMedknow · India | 0.59Q3 | 1.19 0.11 up from 2016 | 141 | 100% | — | ||
48Journal of Pediatric Hematology/OncologyLippincott Williams & Wilkins · United States | 0.57Q3 | 1.17 0.18 down from 2016 | 623 | 12% | — | ||
49Hematology ReportsOAPAGEPress (Italy) | 0.56Q3 | 1.61 0.45 up from 2016 | 70 | 100% | $1,930 | ||
50Leukemia Research ReportsOAElsevier BV · Netherlands | 0.55Q3 | 1.10 0.32 down from 2016 | 66 | 100% | $1,180 |
Subfields of Medicine, with Hematology highlighted.
- Surgery852
- Pulmonary and Respiratory Medicine324
- Public Health, Environmental and Occupational Health270
- Cardiology and Cardiovascular Medicine266
- Oncology213
- Infectious Diseases198
- Epidemiology185
- Neurology157
- Endocrinology, Diabetes and Metabolism156
- Radiology, Nuclear Medicine and Imaging144
- Physiology143
- Psychiatry and Mental health142
- Orthopedics and Sports Medicine107
- Pediatrics, Perinatology and Child Health97
- Ophthalmology87
- Dermatology83
- Hematology74
- Obstetrics and Gynecology68
- Rheumatology65
- Nephrology58
- Reproductive Medicine50
- Complementary and alternative medicine47
- Pharmacology46
- Emergency Medicine38
- Geriatrics and Gerontology35
- Otorhinolaryngology32
- Rehabilitation29
- Pathology and Forensic Medicine25
- Critical Care and Intensive Care Medicine23
- Hepatology23
- Genetics21
- Immunology and Allergy20
- Urology13
- Anesthesiology and Pain Medicine12
- Gastroenterology7
- Internal Medicine4
- Family Practice3
- Transplantation3
- Health Informatics2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2017. Corpus-wide, 77.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
28 additional Hematology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2014–2016, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2017. Publication window: 2014–2016. How these summaries are calculated
- Ranked journals
- 74
- Window papers (baseline)
- 36,578 +9.2% from indicator year 2014
- Median OJR
- 0.75 +4.6% from indicator year 2014
- Rising journals (2025)
- 5
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2014–2016 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 37 | 43 | 47 | 48 | 49 | 48 | 48 | 51 | 52 | 55 | 57 | 59 | 60 | 64 | 69 | 71 | 70 | 74 | 78 | 80 | 79 | 83 | 83 | 84 | 83 | 78 | |
| Window papers (baseline) | 15,676 | 17,554 | 18,321 | 19,931 | 20,773 | 22,160 | 23,086 | 23,968 | 25,638 | 27,756 | 31,370 | 32,535 | 33,270 | 32,125 | 33,484 | 34,476 | 35,772 | 36,578 | 37,717 | 39,004 | 40,629 | 43,037 | 45,948 | 47,337 | 47,502 | 47,302 | |
| Median OJR | 0.53 | 0.57 | 0.589 | 0.593 | 0.641 | 0.646 | 0.677 | 0.650 | 0.640 | 0.663 | 0.62 | 0.73 | 0.707 | 0.713 | 0.7205 | 0.716 | 0.7196 | 0.75 | 0.74 | 0.68294 | 0.711 | 0.682 | 0.68287 | 0.63 | 0.587 | 0.658 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.